Mylan Quick Ratio 2006-2019 | MYL

Historical quick ratio values for Mylan (MYL) over the last 10 years.
Mylan Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2019-03-31 $3.55B $4.16B 0.86
2018-12-31 $3.79B $4.59B 0.83
2018-09-30 $3.98B $5.18B 0.77
2018-06-30 $3.74B $4.86B 0.77
2018-03-31 $4.12B $6.39B 0.65
2017-12-31 $4.67B $6.39B 0.73
2017-09-30 $4.72B $4.98B 0.95
2017-06-30 $4.36B $5.17B 0.84
2017-03-31 $4.52B $4.52B 1.00
2016-12-31 $5.07B $5.04B 1.01
2016-09-30 $5.28B $9.55B 0.55
2016-06-30 $10.00B $3.78B 2.65
2016-03-31 $4.48B $3.96B 1.13
2015-12-31 $4.52B $4.12B 1.10
2015-09-30 $4.54B $3.68B 1.23
2015-06-30 $5.96B $5.37B 1.11
2015-03-31 $5.52B $5.29B 1.04
2014-12-31 $4.79B $5.30B 0.90
2014-09-30 $4.11B $4.47B 0.92
2014-06-30 $2.69B $2.60B 1.03
2014-03-31 $2.60B $2.65B 0.98
2013-12-31 $2.81B $2.96B 0.95
2013-09-30 $2.70B $2.56B 1.05
2013-06-30 $2.58B $2.33B 1.11
2013-03-31 $2.33B $2.28B 1.02
2012-12-31 $2.38B $2.19B 1.08
2012-09-30 $2.26B $2.17B 1.04
2012-06-30 $2.28B $2.16B 1.05
2012-03-31 $2.25B $2.11B 1.07
2011-12-31 $2.17B $2.56B 0.85
2011-09-30 $2.22B $2.38B 0.94
2011-06-30 $2.35B $2.52B 0.93
2011-03-31 $2.43B $2.39B 1.02
2010-12-31 $2.32B $1.81B 1.28
2010-09-30 $2.24B $1.72B 1.30
2010-06-30 $2.53B $1.63B 1.55
2010-03-31 $2.20B $1.64B 1.34
2009-12-31 $2.17B $1.72B 1.26
2009-09-30 $2.14B $1.58B 1.35
2009-06-30 $1.95B $1.42B 1.37
2009-03-31 $1.89B $1.34B 1.41
2008-12-31 $2.11B $1.55B 1.37
2008-09-30 $2.30B $1.82B 1.26
2008-06-30 $2.33B $2.11B 1.10
2008-03-31 $2.35B $2.22B 1.06
2007-12-31 $2.00B $2.00B 1.00
2007-09-30 $2.19B $0.77B 2.85
2007-06-30 $2.19B $0.83B 2.64
2007-03-31 $1.98B $0.70B 2.83
2006-12-31 $0.96B $0.29B 3.36
2006-09-30 $1.03B $0.26B 3.96
2006-06-30 $1.00B $0.29B 3.43
2006-03-31 $0.91B $0.27B 3.44
2005-12-31 $0.92B $0.26B 3.49
2005-09-30 $1.01B $0.27B 3.76
2005-06-30 $1.31B $0.26B 4.94
2005-03-31 $1.24B $0.25B 5.06
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $8.773B $11.434B
Mylan NV is a pharmaceutical company. The company develops, licenses, manufactures, markets and distributes generic and specialty pharmaceuticals. It operates primarily in the United States, Canada, Europe, the Middle East, Africa, India, Australia, Japan and New Zealand. Mylan NV, formerly known as Mylan Inc., is based in Canonsburg, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $37.999B 6.92
Teva Pharmaceutical Industries (TEVA) Israel $8.379B 3.28
Bausch Health Cos (BHC) Canada $7.555B 5.16
Dr Reddy's Laboratories (RDY) India $6.155B 23.02
Supernus Pharmaceuticals (SUPN) United States $1.645B 16.44
Amphastar Pharmaceuticals (AMPH) United States $0.933B 52.16
Voyager Therapeutics (VYGR) United States $0.893B 0.00
Homology Medicines (FIXX) United States $0.809B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.778B 1.16
Akorn (AKRX) United States $0.535B 0.00
CymaBay Therapeutics (CBAY) United States $0.431B 0.00
Assembly Biosciences (ASMB) United States $0.371B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.347B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.275B 0.00
Sol-Gel Technologies (SLGL) Israel $0.161B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.125B 0.00
Acasti Pharma (ACST) Canada $0.071B 0.00
Agile Therapeutics (AGRX) United States $0.058B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.054B 0.00
Teligent (TLGT) United States $0.030B 0.00
Evoke Pharma (EVOK) United States $0.015B 0.00
Aevi Genomic Medicine (GNMX) United States $0.011B 0.00